echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Humanwell medicine obtained 89.76 million yuan of "13th five year plan" special fund

    Humanwell medicine obtained 89.76 million yuan of "13th five year plan" special fund

    • Last Update: 2018-11-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On November 21, humanwell pharmaceutical released the announcement of humanwell Pharmaceutical Group Co., Ltd on obtaining government subsidies, which showed that the Management Committee of Wuhan East Lake New Technology Development Zone allocated special funds to humanwell pharmaceutical for the 13th five year plan, 9.769 million yuan is specially used to subsidize and reward the company's R & D expenses, scientific and technological innovation achievements and qualifications, fixed asset investment, international strategy, talents and public service platforms during the 13th Five Year Plan period The full text is as follows:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.